PTK2B (Ab-579) Antibody

Shipped with Ice Packs
In Stock

Description

Target and Biological Significance

PTK2B (Protein Tyrosine Kinase 2 Beta), also known as PYK2, is a non-receptor tyrosine kinase regulating cytoskeletal reorganization, cell migration, immune responses, and bone remodeling . Phosphorylation at Tyr579 facilitates interactions with SRC family kinases, activating downstream pathways like MAPK and Rho GTPases . Dysregulation of PTK2B is linked to inflammatory diseases, including ulcerative colitis (UC), where elevated PTK2B levels correlate with neutrophil activation and mucosal inflammation .

Mechanistic Studies

  • UC Pathogenesis: PTK2B (Ab-579) detects elevated PTK2B levels in inflamed colonic mucosa of UC patients, correlating with disease severity .

  • Neutrophil Migration: Validates PTK2B’s role in neutrophil migration via CXCR2/GRK2-p38 MAPK signaling .

Functional Assays

  • Western Blot: Confirms PTK2B expression in 3T3 cells (mouse fibroblasts) .

  • Phosphorylation Analysis: Distinguishes activated PTK2B in signaling cascades, such as SRC-mediated pathways .

Validation and Quality Control

  • Specificity Testing: Pre-adsorption with phosphorylated immunogen abolishes signal, confirming epitope specificity .

  • Cross-Reactivity: Validated in human, mouse, and rat tissues .

Related Antibodies

  • Phospho-specific variants: Anti-PTK2B (pTyr402) .

  • Epitope coverage: Antibodies targeting AA 1-1009 (full-length) or AA 805-838 (C-terminal) .

Implications in Biomedical Research

PTK2B (Ab-579) Antibody enables critical investigations into:

  • Immune Dysregulation: Mechanistic links between PTK2B phosphorylation and UC progression .

  • Cell Signaling: Role in integrin, GPCR, and cytokine receptor pathways .

  • Therapeutic Targeting: Screening inhibitors (e.g., TAE226) that modulate PTK2B activity .

Product Specs

Form
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Lead Time
Typically, we can ship the products within 1-3 business days after receiving your orders. Delivery timelines may vary depending on the purchasing method or location. Please consult your local distributors for specific delivery information.
Synonyms
CADTK antibody; CAK-beta antibody; CAKB antibody; CAKbeta antibody; Calcium regulated non receptor proline rich tyrosine kinase antibody; Calcium-dependent tyrosine kinase antibody; Cell adhesion kinase beta antibody; E430023O05Rik antibody; EC 2.7.10.2 antibody; FADK 2 antibody; FADK2 antibody; FAK2 antibody; FAK2_HUMAN antibody; Focal adhesion kinase 2 antibody; MGC124628 antibody; PKB antibody; Proline-rich tyrosine kinase 2 antibody; Protein kinase B antibody; Protein Tyrosine Kinase 2 Beta antibody; Protein-tyrosine kinase 2-beta antibody; PTK antibody; PTK2B antibody; PTK2B protein tyrosine kinase 2 beta antibody; PYK2 antibody; RAFTK antibody; RAFTK2 antibody; Related adhesion focal tyrosine kinase antibody
Target Names
Uniprot No.

Target Background

Function
Proline-rich tyrosine kinase 2 beta (PTK2B), also known as PYK2, is a non-receptor protein-tyrosine kinase that plays a crucial role in regulating the reorganization of the actin cytoskeleton. It influences various cellular processes, including cell polarization, migration, adhesion, spreading, and bone remodeling. PTK2B is essential for normal humoral immune responses and contributes to the regulation of marginal B-cell levels in the spleen, as well as the normal migration of splenic B-cells. It is also involved in regulating macrophage polarization and migration towards inflammatory sites. PTK2B further regulates cytoskeleton rearrangement and cell spreading in T-cells, impacting the modulation of T-cell responses. This kinase promotes osteoclastic bone resorption, a process that necessitates the involvement of both PTK2B/PYK2 and SRC. It may also inhibit the differentiation and activity of osteoprogenitor cells. PTK2B functions as a downstream signaling mediator of integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCR), cytokine, chemokine, and growth factor receptors, mediating cellular responses to stress. Upon activation, PTK2B forms multisubunit signaling complexes with SRC and SRC family members, leading to the phosphorylation of additional tyrosine residues. These phosphorylated residues serve as binding sites for scaffold proteins, effectors, and substrates, thus regulating numerous signaling pathways. PTK2B promotes the activation of phosphatidylinositol 3-kinase and the AKT1 signaling cascade, leading to the activation of NOS3 and the regulation of cGMP production. It also promotes the activation of the MAP kinase signaling cascade, including MAPK1/ERK2, MAPK3/ERK1, and MAPK8/JNK1. Additionally, PTK2B facilitates the activation of Rho family GTPases, such as RHOA and RAC1. PTK2B recruits the ubiquitin ligase MDM2 to P53/TP53 in the nucleus, thereby regulating P53/TP53 activity, ubiquitination, and proteasomal degradation. Acting as a scaffold, PTK2B binds to both PDPK1 and SRC, allowing SRC to phosphorylate PDPK1 at 'Tyr-9', 'Tyr-373', and 'Tyr-376'. This kinase promotes phosphorylation of NMDA receptors by SRC family members, contributing to the regulation of NMDA receptor ion channel activity and intracellular Ca(2+) levels. It may also regulate potassium ion transport by phosphorylating potassium channel subunits. PTK2B phosphorylates SRC, enhancing its kinase activity. It further phosphorylates ASAP1, NPHP1, KCNA2, and SHC1, and promotes the phosphorylation of ASAP2, RHOU, and PXN, a process that requires both SRC and PTK2/PYK2.
Gene References Into Functions
  1. LFA-1 cross-linking recruits and activates FAK1 and PYK2 to phosphorylate LAT selectively on a single Y-171 site. This binding to the GRB2-SKAP1 complex limits dwell times of T-cells with dendritic cells. PMID: 28699640
  2. Pyk2 plays a role in spine structure and synaptic function. Its deficiency contributes to cognitive impairments associated with Huntington's disease. PMID: 28555636
  3. Research indicates that Pyk2 phosphorylates STIM1 at its Y361 residue, activating store-operated Ca(2+) entry. PMID: 28218251
  4. Findings identify Pyk2 as a unique mediator of invadopodium formation and function, providing a novel insight into the mechanisms by which Pyk2 mediates tumor cell invasion. PMID: 29133485
  5. Research demonstrates that VEGFA induces Pyk2 activation, playing a critical role in mediating human retinal microvascular endothelial cell migration, sprouting, and tube formation. Pyk2-mediated STAT3 activation is essential for hypoxia-induced retinal neovascularization. PMID: 27210483
  6. Interestingly, the rs2279590 locus exhibits a widespread enhancer effect on two nearby genes, protein tyrosine kinase 2 beta (PTK2B) and epoxide hydrolase-2 (EPHX2). Both of these genes have been previously linked to Alzheimer's disease as risk factors. PMID: 28973302
  7. Multiple myeloma, driven by deregulated iron homeostasis and/or Pyk2/beta-cateninn signaling, is susceptible to deferasirox-induced apoptosis. PMID: 27602957
  8. Data suggests that PYK2, through S6K1 activation, modulates AR function and growth properties in prostate cancer cells. Therefore, PYK2 and S6K1 may serve as potential therapeutic targets for prostate cancer treatment. PMID: 27492635
  9. Findings indicate that Pyk2 plays a significant role in the coordination of beta-catenin stabilization within the crosstalk between Wnt/beta-catenin and Wnt/Ca(2+) signaling pathways upon Wnt3a stimulation in differentiating human neural progenitor cells. PMID: 28694190
  10. STIM1-induced Ca(2+) signaling activates Pyk2 to inhibit the interaction of VE-PTP and VE-cadherin, thereby increasing endothelial permeability. PMID: 28385807
  11. Ascites and CCL18 stimulate the phosphorylation and expression of Pyk2, which positively regulates ascites-induced ovarian cancer cell migration. PMID: 27613122
  12. Research demonstrates trophoblast cytoprotection by intervention with supraphysiological concentrations of relaxin, a process partially mediated through the PI3-kinase-Akt/PKB cell survival pathway. These findings provide further rationale for clinical investigation of relaxin as a potential therapeutic agent in preeclampsia. PMID: 28122716
  13. PTK2B polymorphism (rs28834970) might modify the risk of late-onset Alzheimer's disease (LOAD). Additionally, PTK2B polymorphism (rs28834970) and APOE may interact to increase LOAD risk in a Han Chinese population. PMID: 27080426
  14. Studies suggest that PYK2 is a common downstream effector of ErbB and IL8 receptors, and that PYK2 integrates their signaling pathways through a positive feedback loop to potentiate breast cancer invasion. PMID: 26084289
  15. Pyk2 is a key downstream signaling molecule of CCR7 in squamous cell carcinoma of the head and neck, promoting tumorigenesis and progression. PMID: 26352169
  16. Phosphoproteomic analysis identifies FAK2 as a potential therapeutic target for tamoxifen resistance in breast cancer. PMID: 26330541
  17. The Pyk2-focal adhesion targeting domain interacts with and binds to leupaxin. PMID: 26866573
  18. Src plays a role in priming Pyk2 (but not FAK) phosphorylation and subsequent activation downstream of integrins. PMID: 26866924
  19. Data strongly suggests that chemokine-stimulated associations between Vav1, SLP-76, and ADAP facilitate Rac1 activation and alpha4beta1-mediated adhesion, while Pyk2 opposes this adhesion by limiting Rac1 activation. PMID: 26202465
  20. FAK and PYK2 function redundantly to promote the Wnt/beta-catenin pathway by phosphorylating GSK3beta(Y216) to reinforce pathway output-beta-catenin accumulation and intestinal tumorigenesis. PMID: 26274564
  21. This study identified Pyk2 as a cellular component required for the intracellular trafficking of HPV16 during infection. PMID: 26109718
  22. Results suggest that melatonin exerts anti-migratory and anti-invasive effects on glioma cells in response to hypoxia via reactive oxygen species-alphavbeta3 integrin-FAK/Pyk2 signaling pathways. PMID: 25889845
  23. Data suggest a novel role for FAK in GPVI-dependent ROS formation and platelet activation and elucidate a proximal signaling role for FAK within the GPVI pathway. PMID: 25415317
  24. The Orai1/Pyk2 pathway is essential for glioma migration and invasion. PMID: 25433371
  25. The Pyk2-NDRG1 axis is possibly involved in conveying the anti-proliferative effect of beta-ionone in prostate cancer cells. PMID: 25219547
  26. Pyk2 plays a role in integrin regulation of the size and dynamics of signaling microclusters. PMID: 25778396
  27. PYK2 is an intermediary component of Ca(2+) signaling between PKA-mediated and Tyr phosphorylations, essential for achieving functional human sperm capacitation. PMID: 25180269
  28. Data indicate that chicken paxillin leucine-aspartate LD2 and LD4 motifs preferentially dock at the helix 2/3 binding site of human Proline-rich tyrosine kinase 2 (Pyk2)-focal adhesion kinase (FAK). PMID: 25174335
  29. These data demonstrate that Pyk2 is a critical regulator of PI3K function downstream of the TCR. PMID: 25387834
  30. Data indicate the tumor-promoting role of proline-rich tyrosine kinase 2 (Pyk2) in multiple myeloma (MM), suggesting tyrosine kinase inhibitor as a therapeutic option in MM. PMID: 25217697
  31. Inhibition of FAK, PYK2, and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines. PMID: 24523919
  32. Pyk2 and Src are crucial for CCL18-induced breast cancer metastasis. PMID: 24142406
  33. High expression of proline-rich tyrosine kinase 2 is associated with hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway. PMID: 22618716
  34. Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation. PMID: 24097630
  35. Pyk2 is essential for skin wound reepithelialization in vivo and in vitro. It regulates epidermal keratinocyte migration through a pathway involving PKCdelta and MMP functions. PMID: 24598361
  36. Pyk2 is a shared key mediator of targeted-therapy induced adhesion and migration. Targeting Pyk2 may serve as an effective therapeutic strategy to reduce extramedullary relapse in acute promyelocytic leukemia and chronic myeloid leukemia. PMID: 24176282
  37. We hypothesize a potential direct or indirect role for SRC, RAF1, PTK2B genes in neurotransmission and in central nervous system signaling processes. PMID: 24108181
  38. Research determines a crucial role for LRP1-mediated Pyk2 phosphorylation on hypoxia-induced MMP-9 activation and human vascular smooth muscle cell migration, contributing to hypoxia-induced vascular remodeling. PMID: 24072693
  39. Both Pyk2 and phosphorylated Pyk2[pY881] are potential prognostic factors and therapeutic targets for non-small-cell lung cancer. PMID: 23922106
  40. Results confirm that receptor tyrosine kinases (RTKs) are frequently altered in chordomas. PMID: 23618355
  41. Results indicate that in vitro, Pyk2 might function to regulate cell adhesion and motility following all-trans-retinoic acid (ATRA) treatment. PMID: 23587524
  42. We conclude that the effects of selenoprotein H on mitochondrial biogenesis and mitochondrial function are likely mediated through protein kinase A-CREB-PGC-1alpha and Akt/protein kinase B-CREB-PGC-1alpha pathways. PMID: 23220172
  43. Data indicate protein secretion pathways activated by monosodium urate (MSU) in macrophages, revealing a novel role for cathepsin B and Src, Pyk2, PI3 kinases in the activation of unconventional protein secretion. PMID: 23292187
  44. These results identify a novel pathway of integrin alphaIIbbeta3 outside-in signaling and recognize the tyrosine kinase Pyk2 as a major regulator of platelet adhesion and spreading on fibrinogen. PMID: 23216754
  45. The non-catalytic functions of the kinases Fyn and Pyk2 were required for late stage human T cell adhesion. PMID: 23300847
  46. SOCS3 definitively plays roles in regulating Pyk2 signaling and cell motility in A549 cells. PMID: 23302305
  47. PAC1 regulates PYK-2 tyrosine phosphorylation in a calcium-dependent manner in lung cancer cell lines. PMID: 22581436
  48. Findings showed that Pyk2 is overexpressed in squamous cell carcinoma of the head and neck. Data suggest that CCR7 via Pyk2 and cofilin regulates the chemotaxis and migration ability of metastatic squamous cell carcinoma of the head and neck cells. PMID: 22923218
  49. Down-regulation of both miR-517a and miR-517c contribute to hepatocellular carcinoma cells development through regulating Pyk2. PMID: 23142219
  50. Pyk2, which was strongly activated by IGF-I, was critical for IGF-IR-dependent motility. PMID: 22859931

Show More

Hide All

Database Links

HGNC: 9612

OMIM: 601212

KEGG: hsa:2185

STRING: 9606.ENSP00000332816

UniGene: Hs.491322

Involvement In Disease
Aberrant PTK2B/PYK2 expression may play a role in cancer cell proliferation, migration and invasion, in tumor formation and metastasis. Elevated PTK2B/PYK2 expression is seen in gliomas, hepatocellular carcinoma, lung cancer and breast cancer.
Protein Families
Protein kinase superfamily, Tyr protein kinase family, FAK subfamily
Subcellular Location
Cytoplasm. Cytoplasm, perinuclear region. Cell membrane; Peripheral membrane protein; Cytoplasmic side. Cell junction, focal adhesion. Cell projection, lamellipodium. Cytoplasm, cell cortex. Nucleus. Note=Interaction with NPHP1 induces the membrane-association of the kinase. Colocalizes with integrins at the cell periphery.
Tissue Specificity
Most abundant in the brain, with highest levels in amygdala and hippocampus. Low levels in kidney (at protein level). Also expressed in spleen and lymphocytes.

Q&A

What is PTK2B and what cellular functions does it regulate?

PTK2B (also known as PYK2, FAK2, or RAFTK) is a non-receptor protein-tyrosine kinase that plays crucial roles in multiple cellular processes. It regulates reorganization of the actin cytoskeleton, cell polarization, cell migration, adhesion, spreading, and bone remodeling . In immune cells, PTK2B is required for normal levels of marginal B-cells in the spleen, normal migration of splenic B-cells, and proper macrophage polarization and migration towards sites of inflammation . PTK2B functions downstream of numerous receptor types, including integrin and collagen receptors, immune receptors, G-protein coupled receptors (GPCRs), and cytokine/chemokine/growth factor receptors . It also mediates responses to cellular stress through formation of multisubunit signaling complexes with SRC and SRC family members, leading to phosphorylation events that create binding sites for scaffold proteins, effectors, and substrates .

What is the significance of Tyrosine 579 phosphorylation in PTK2B?

Tyrosine 579 (Tyr579) represents an important phosphorylation site in PTK2B that occurs downstream of initial Tyr402 phosphorylation. The phosphorylation sequence typically follows this pattern: phosphorylation at Tyr-402 promotes interaction with SRC and SRC family members, leading to subsequent phosphorylation at Tyr-579, Tyr-580, and Tyr-881 . Specifically, phosphorylation at Tyr579 occurs after PTK2B interacts with SRC family kinases and is critical for full kinase activation and downstream signaling events . This phosphorylation site is part of a regulatory mechanism that controls PTK2B's ability to activate numerous signaling pathways, including the MAP kinase cascade, Rho family GTPases, and AKT signaling .

How is PTK2B (Ab-579) Antibody generated and what is its specificity?

PTK2B (Ab-579) Antibody is typically generated using a synthesized non-phosphopeptide derived from human PYK2 around the phosphorylation site of tyrosine 579 with the amino acid sequence E-D-Y(p)-Y-K . The antibody is produced in rabbits and is polyclonal in nature . After collection, the antibody is affinity-purified from rabbit antiserum using affinity-chromatography with the epitope-specific immunogen .

The specificity of the antibody depends on the exact product. Some versions detect endogenous levels of total PYK2 protein regardless of phosphorylation state , while phospho-specific versions detect PYK2 protein only when phosphorylated at Y579 . The antibody shows cross-reactivity with human and mouse PTK2B .

Based on the provided information, PTK2B (Ab-579) Antibody demonstrates reactivity with:

  • Human PTK2B

  • Mouse PTK2B

  • Rat PTK2B (for some versions of the antibody)

This cross-species reactivity makes the antibody useful for comparative studies across different model systems. Western blot analyses specifically show detection of PTK2B in human cell lines and mouse 3T3 cells .

How should I optimize Western blot conditions for PTK2B (Ab-579) Antibody?

For optimal Western blot results with PTK2B (Ab-579) Antibody, follow these methodological recommendations:

  • Sample preparation: Prepare cell or tissue lysates in a buffer containing phosphatase inhibitors to preserve phosphorylation status. PTK2B is approximately 116-125 kDa.

  • Antibody dilution: Start with a 1:1000 dilution and adjust based on signal strength. The recommended dilution range is 1:500-1:3000 .

  • Blocking conditions: Use 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature. For phospho-specific detection, BSA is preferred over milk as blocking agent.

  • Incubation time and temperature: Primary antibody incubation should be performed overnight at 4°C for optimal results.

  • Controls: Include a positive control (e.g., 3T3 cells) that is known to express PTK2B . Consider using a peptide competition assay as demonstrated in Western blot analyses where the lane treated with synthesized peptide shows eliminated or reduced signal .

  • Detection system: Both chemiluminescence and fluorescence-based detection systems are suitable, with the choice depending on the desired sensitivity and equipment availability.

What cellular models are most appropriate for studying PTK2B phosphorylation at Tyr579?

Based on the available data, the following cellular models have been successfully used to study PTK2B phosphorylation at Tyr579:

  • 3T3 cells: Mouse fibroblast cells show detectable levels of PTK2B and have been used in Western blot validation of the antibody .

  • Jurkat cells: Human T lymphocyte cells demonstrate expression of PTK2B and are useful for studying PTK2B in immune signaling contexts .

  • RAW264.7 cells: Murine macrophage cell line expresses PTK2B and is valuable for studying PTK2B in the context of innate immune responses .

  • A431 cells: Human epidermoid carcinoma cells express PTK2B and have been used for immunocytochemistry applications .

When selecting a cellular model, consider the following factors:

  • The signaling pathway of interest (immune, adhesion, migration)

  • Species compatibility with the antibody

  • Endogenous expression levels of PTK2B

  • Presence of stimuli that can induce PTK2B phosphorylation

How do I properly validate the specificity of PTK2B (Ab-579) Antibody in my experiments?

To properly validate the specificity of PTK2B (Ab-579) Antibody for your experiments, follow these methodological approaches:

  • Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application to your sample. The specific signal should be significantly reduced or eliminated, as demonstrated in Western blot analyses where the lane treated with synthesized peptide shows eliminated signal .

  • Phosphatase treatment: For phospho-specific antibodies, treat half of your sample with lambda phosphatase to remove phosphate groups. The signal should disappear in the treated sample if the antibody is truly phospho-specific.

  • Genetic approaches: Use PTK2B knockdown or knockout cell lines/tissues as negative controls. The specific band or staining should be absent in these samples.

  • Multiple detection methods: Confirm your findings using alternative methods (e.g., mass spectrometry) or different antibodies targeting other regions of PTK2B.

  • Cross-reactivity assessment: Test the antibody on samples known to express closely related proteins (like PTK2/FAK1) to ensure it does not cross-react with these proteins.

What controls should be included when using PTK2B (Ab-579) Antibody in phosphorylation studies?

For rigorous phosphorylation studies using PTK2B (Ab-579) Antibody, include these essential controls:

  • Positive control: Cell lysate or tissue known to express phosphorylated PTK2B at Tyr579, such as 3T3 cells .

  • Negative control:

    • Unstimulated cells (basal conditions where phosphorylation is minimal)

    • Samples treated with tyrosine kinase inhibitors that block PTK2B activation

    • Phosphatase-treated samples

  • Peptide competition control: Antibody pre-incubated with the immunizing peptide to demonstrate specificity .

  • Antibody controls:

    • Primary antibody omission control

    • Isotype control (rabbit IgG)

    • Total PTK2B antibody to assess total protein levels alongside phosphorylation status

  • Loading control: Antibody against housekeeping protein (β-actin, GAPDH) to ensure equal loading across samples.

  • Stimulation experiments: Controlled treatments that induce PTK2B phosphorylation, such as:

    • Calcium ionophores (PTK2B is calcium-dependent)

    • Angiotensin II

    • Thapsigargin

    • L-alpha-lysophosphatidic acid (LPA)

What is the recommended protocol for immunoprecipitation using PTK2B (Ab-579) Antibody?

While the provided search results don't specifically detail an immunoprecipitation (IP) protocol for PTK2B (Ab-579) Antibody, some variants of anti-PTK2B antibodies are validated for IP . Based on general IP principles and the properties of this antibody, here is a recommended protocol:

  • Cell lysis:

    • Harvest cells and lyse in non-denaturing lysis buffer (e.g., 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate)

    • Include protease inhibitors (e.g., PMSF, aprotinin, leupeptin)

    • For phosphorylation studies, add phosphatase inhibitors (e.g., sodium orthovanadate, sodium fluoride, β-glycerophosphate)

    • Clear lysate by centrifugation (14,000 × g for 15 minutes at 4°C)

  • Pre-clearing (optional but recommended):

    • Incubate lysate with Protein A/G beads for 1 hour at 4°C

    • Remove beads by centrifugation

  • Immunoprecipitation:

    • Add 2-5 μg of PTK2B (Ab-579) Antibody to 500 μg-1 mg of pre-cleared lysate

    • Incubate overnight at 4°C with gentle rotation

    • Add 30-50 μL of Protein A beads (as the primary antibody is rabbit-derived)

    • Incubate for 2-4 hours at 4°C with gentle rotation

  • Washing:

    • Collect beads by centrifugation at 2,000 × g for 2-3 minutes

    • Wash 3-5 times with lysis buffer

  • Elution and Analysis:

    • Elute proteins by boiling beads in SDS sample buffer

    • Analyze by SDS-PAGE and Western blotting

  • Controls:

    • Input control (5-10% of lysate used for IP)

    • Negative control using rabbit IgG instead of specific antibody

How do I interpret Western blot results when using PTK2B (Ab-579) Antibody?

When interpreting Western blot results using PTK2B (Ab-579) Antibody, consider these key points:

  • Expected band size: PTK2B has a molecular weight of approximately 116-125 kDa. Verify that your detected band appears at this size.

  • Phosphorylation status interpretation:

    • If using a phospho-specific antibody, the signal intensity reflects the relative level of Tyr579 phosphorylation

    • Compare with total PTK2B levels using a non-phospho-specific antibody in parallel samples

    • Calculate the phospho-PTK2B/total PTK2B ratio to quantify relative phosphorylation levels

  • Multiple bands interpretation:

    • A band at ~42 kDa may represent a proteolytic fragment or isoform of PTK2B called PRNK (PYK2-Related Non-Kinase)

    • Multiple bands near the expected size might indicate post-translational modifications or splice variants

    • Non-specific bands can be identified using peptide competition controls

  • Stimulation experiments:

    • Increased signal intensity after treatments known to activate PTK2B (calcium flux inducers, angiotensin II, etc.) confirms antibody specificity and PTK2B activation

    • The timing of phosphorylation may vary depending on stimulus and cell type

  • Quantitative analysis:

    • Use densitometry to quantify band intensity

    • Normalize to loading controls

    • Present data as fold-change relative to control conditions

What might cause false positive or false negative results when using PTK2B (Ab-579) Antibody?

Several factors can lead to false positive or false negative results when using PTK2B (Ab-579) Antibody:

Potential causes of false positives:

  • Cross-reactivity: The antibody might recognize structurally similar proteins, especially other FAK family members.

  • Non-specific binding: Insufficient blocking or high antibody concentration can lead to non-specific signals.

  • Sample contamination: Contamination during sample preparation can introduce proteins that generate non-specific signals.

  • Detection system issues: Excessive exposure time or highly sensitive detection reagents can amplify background signals.

  • Secondary antibody cross-reactivity: The secondary antibody might recognize endogenous immunoglobulins in your sample.

Potential causes of false negatives:

  • Protein degradation: Improper sample handling or insufficient protease inhibitors can lead to PTK2B degradation.

  • Phosphatase activity: Inadequate phosphatase inhibition during sample preparation can result in dephosphorylation of Tyr579.

  • Epitope masking: Protein-protein interactions or other post-translational modifications might block antibody access to the epitope.

  • Insufficient protein loading: Too little protein loaded can result in signal below detection threshold.

  • Inefficient transfer: Problems during protein transfer from gel to membrane can reduce signal intensity.

  • Antibody storage issues: Improper storage conditions (repeated freeze-thaw cycles, inappropriate temperature) can reduce antibody activity .

How does phosphorylation at Tyr579 affect PTK2B interaction with other signaling proteins?

Phosphorylation at Tyr579 in PTK2B plays a critical role in protein-protein interactions and downstream signaling:

  • Sequential phosphorylation events: Tyr579 phosphorylation typically occurs after initial autophosphorylation at Tyr402. The process generally follows this sequence: phosphorylation at Tyr-402 promotes interaction with SRC and SRC family members, leading to subsequent phosphorylation at Tyr-579, Tyr-580, and Tyr-881 .

  • SRC family kinase interactions: Phosphorylation at Tyr579 (along with Tyr580) creates binding sites for SH2 domain-containing proteins, particularly SRC family kinases, stabilizing their interaction with PTK2B and facilitating full kinase activation .

  • Scaffold function: Phosphorylated PTK2B acts as a scaffold for the assembly of multiprotein signaling complexes. For example, it can bind to both PDPK1 and SRC, thereby allowing SRC to phosphorylate PDPK1 at multiple tyrosine residues .

  • Downstream effector activation: Tyr579 phosphorylation contributes to PTK2B's ability to activate multiple signaling pathways, including:

    • MAP kinase cascade (ERK1/2, JNK1)

    • Rho family GTPases (RHOA, RAC1)

    • Phosphatidylinositol 3-kinase and AKT1 signaling cascade

    • NOS3 activation and cGMP production

  • Cytoskeletal regulation: Phosphorylated PTK2B regulates focal adhesion dynamics, cell migration, and cytoskeletal reorganization through interactions with proteins like paxillin (PXN) and ASAP1/2 .

How can I distinguish between specific PTK2B phosphorylation signal and background in immunofluorescence?

To distinguish specific PTK2B phosphorylation signal from background in immunofluorescence experiments:

  • Proper controls:

    • Include a negative control with primary antibody omitted

    • Use isotype control antibody (rabbit IgG) at the same concentration

    • Perform peptide competition by pre-incubating the antibody with immunizing peptide

    • Include positive controls (cells known to express phosphorylated PTK2B)

  • Optimization strategies:

    • Titrate antibody concentration (start with 1:50-1:200 dilution)

    • Optimize fixation method (4% paraformaldehyde is generally suitable)

    • Implement antigen retrieval if needed

    • Use proper permeabilization (0.1-0.5% Triton X-100)

    • Extend blocking time to reduce non-specific binding

  • Signal validation techniques:

    • Compare staining pattern with known PTK2B localization (cytoplasm, perinuclear region, cell membrane, focal adhesions, lamellipodia)

    • Co-stain with antibodies against proteins known to colocalize with PTK2B (SRC, integrins)

    • Treat cells with stimuli known to induce PTK2B phosphorylation and observe increased signal

    • Compare with cells where PTK2B expression is knocked down

  • Image acquisition and analysis:

    • Use identical exposure settings for all samples

    • Collect z-stacks to capture the full signal distribution

    • Implement quantitative image analysis to measure signal intensity relative to background

    • Consider advanced techniques like FRET if assessing protein-protein interactions

What is the relationship between Tyr402 and Tyr579 phosphorylation in PTK2B signaling cascades?

The relationship between Tyr402 and Tyr579 phosphorylation represents a sequential activation mechanism in PTK2B signaling:

  • Initiation by Tyr402 phosphorylation:

    • Tyr402 is the major autophosphorylation site of PTK2B

    • This phosphorylation occurs in response to various stimuli that elevate intracellular calcium concentration

    • The activation is often indirect and may be mediated by production of reactive oxygen species (ROS)

    • Autophosphorylation occurs in trans, where one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit

  • Recruitment of SRC family kinases:

    • Phosphorylation at Tyr402 creates a binding site for the SH2 domains of SRC and SRC family members

    • This interaction brings SRC kinases into proximity with PTK2B

  • Secondary phosphorylation events:

    • SRC and SRC family kinases then phosphorylate additional tyrosine residues on PTK2B, including Tyr579, Tyr580, and Tyr881

    • These secondary phosphorylation events are required for full kinase activation and downstream signaling

  • Functional significance:

    • Tyr402 phosphorylation serves as the initiating event in PTK2B activation

    • Tyr579 phosphorylation (along with Tyr580) enhances kinase activity and creates additional protein binding sites

    • Tyr881 phosphorylation is important for interaction with GRB2 and activation of downstream pathways like the MAP kinase cascade

  • Regulatory mechanisms:

    • This sequential phosphorylation creates a mechanism for signal amplification and integration

    • It also provides multiple points for regulation via phosphatases like PTPN12, which can dephosphorylate these sites

How can PTK2B (Ab-579) Antibody be used to study crosstalk between calcium signaling and tyrosine kinase pathways?

PTK2B (Ab-579) Antibody provides a valuable tool for investigating the intersection of calcium signaling and tyrosine kinase pathways:

  • Calcium-dependent activation studies:

    • Use the antibody to detect PTK2B phosphorylation at Tyr579 following treatments with calcium ionophores, thapsigargin (which depletes ER calcium stores), or physiological stimuli that increase intracellular calcium

    • Compare the timing and magnitude of phosphorylation with calcium flux measurements using fluorescent indicators

    • Determine whether calcium-dependent kinases (like CAMKs) act upstream of PTK2B phosphorylation

  • G-protein coupled receptor (GPCR) signaling:

    • Investigate how GPCRs that activate phospholipase C and trigger calcium release affect PTK2B phosphorylation

    • Study the role of PTK2B in integrating GPCR and integrin signaling by examining Tyr579 phosphorylation in cells with manipulated integrin expression or activation

  • Mechanistic studies:

    • Use calcium chelators (BAPTA-AM) to determine calcium-dependency of PTK2B phosphorylation

    • Employ reactive oxygen species (ROS) scavengers to assess the contribution of ROS to calcium-induced PTK2B activation

    • Investigate how calcium signaling influences the formation of complexes between PTK2B and SRC family kinases

  • Downstream pathway integration:

    • Examine how PTK2B phosphorylation at Tyr579 influences calcium-dependent and independent signaling pathways

    • Study the role of PTK2B in calcium-regulated processes like NMDA receptor function and ion channel regulation

    • Investigate PTK2B's contribution to calcium-dependent cellular processes such as migration, adhesion, and cytoskeletal reorganization

  • Temporal dynamics analysis:

    • Use time-course experiments with PTK2B (Ab-579) Antibody to determine the relationship between calcium flux and PTK2B phosphorylation

    • Implement phospho-specific flow cytometry for single-cell resolution of calcium-induced PTK2B activation

What experimental approaches can reveal the temporal dynamics of PTK2B phosphorylation at Tyr579?

To investigate the temporal dynamics of PTK2B phosphorylation at Tyr579, consider these methodological approaches:

  • Time-course Western blot analysis:

    • Stimulate cells with activators of PTK2B (calcium ionophores, angiotensin II, thapsigargin, LPA)

    • Collect samples at multiple time points (e.g., 0, 1, 5, 15, 30, 60, 120 minutes)

    • Analyze PTK2B phosphorylation at Tyr579 using PTK2B (Ab-579) Antibody

    • Quantify phosphorylation levels by densitometry and normalize to total PTK2B

  • Real-time imaging techniques:

    • Generate cells expressing fluorescent protein-tagged PTK2B

    • Use FRET-based biosensors that report on PTK2B phosphorylation status

    • Perform live cell imaging following stimulation

    • Analyze the kinetics of phosphorylation and spatial distribution within cells

  • Phospho-flow cytometry:

    • Fix and permeabilize cells at various time points after stimulation

    • Stain with PTK2B (Ab-579) Antibody and fluorescently labeled secondary antibody

    • Analyze by flow cytometry to quantify phosphorylation at single-cell resolution

    • This approach allows analysis of heterogeneity in the population response

  • Pulse-chase experiments:

    • Stimulate cells briefly, then remove or inhibit the stimulus

    • Monitor the persistence of Tyr579 phosphorylation over time

    • Compare with dephosphorylation dynamics after phosphatase inhibitor treatment

  • Computational modeling:

    • Collect quantitative data on phosphorylation kinetics under various conditions

    • Develop mathematical models of PTK2B activation and phosphorylation

    • Use models to predict and test hypotheses about feedback regulation and signal integration

How can I use PTK2B (Ab-579) Antibody to investigate the role of PTK2B in immune cell migration and function?

PTK2B (Ab-579) Antibody can be utilized in multiple experimental approaches to study PTK2B's role in immune cell migration and function:

  • Immunophenotyping and signaling analysis:

    • Analyze PTK2B phosphorylation at Tyr579 in different immune cell subsets (B cells, T cells, macrophages, dendritic cells)

    • Examine how immunoreceptor engagement affects PTK2B phosphorylation

    • Correlate PTK2B phosphorylation status with immune cell activation markers

  • Migration and chemotaxis assays:

    • Perform Transwell or Boyden chamber migration assays with immune cells

    • Use PTK2B (Ab-579) Antibody to assess Tyr579 phosphorylation before, during, and after chemokine stimulation

    • Correlate phosphorylation levels with migration capacity

    • Compare wild-type cells with PTK2B-knockdown or -inhibited cells

  • Live cell imaging of immune synapse formation:

    • Use PTK2B (Ab-579) Antibody in immunofluorescence studies to visualize PTK2B localization and phosphorylation during immune synapse formation

    • Implement advanced microscopy techniques (TIRF, confocal) to examine spatial distribution

  • In vivo migration studies:

    • Adoptively transfer immune cells into recipient animals

    • Harvest cells from different tissues/organs at various time points

    • Analyze PTK2B phosphorylation status using PTK2B (Ab-579) Antibody

    • Correlate with migration and homing patterns

  • Functional immune assays:

    • Examine how PTK2B phosphorylation status correlates with:

      • Cytokine production

      • Phagocytic capacity (for macrophages and dendritic cells)

      • Antigen presentation

      • T cell proliferation and differentiation

    • Use PTK2B inhibitors or genetic approaches to manipulate PTK2B function and assess consequences

  • Integration with other signaling pathways:

    • Study how PTK2B phosphorylation at Tyr579 coordinates with other immune signaling pathways (e.g., TCR/BCR signaling, integrin signaling)

    • Examine the relationship between PTK2B and calcium mobilization in immune cell activation

What methods can effectively distinguish between PTK2B and related family members like FAK?

Distinguishing between PTK2B (PYK2/FAK2) and its related family member FAK (PTK2) requires careful experimental design:

  • Antibody-based approaches:

    • Use highly specific antibodies targeting unique regions or phosphorylation sites

    • PTK2B (Ab-579) Antibody targets the region around Tyr579, which may have sequence differences from the corresponding region in FAK

    • Validate antibody specificity using overexpression systems or knockout controls

    • Perform side-by-side Western blots with anti-PTK2B and anti-FAK antibodies to compare molecular weights (FAK is approximately 125 kDa, similar to PTK2B)

  • Immunoprecipitation followed by mass spectrometry:

    • Immunoprecipitate with PTK2B (Ab-579) Antibody

    • Analyze the precipitated proteins by mass spectrometry

    • Identify peptides unique to PTK2B versus FAK

    • This approach can also identify specific post-translational modifications and interacting partners

  • Genetic approaches:

    • Use siRNA or shRNA specifically targeting PTK2B or FAK

    • Verify knockdown efficiency with gene-specific primers (qRT-PCR) and protein-specific antibodies

    • Analyze the differential effects of PTK2B versus FAK knockdown on cellular functions

    • Use CRISPR-Cas9 to generate specific knockout cell lines

  • Functional differentiation:

    • Exploit known functional differences between PTK2B and FAK:

      • PTK2B is calcium-responsive while FAK is generally not

      • PTK2B is highly expressed in specific cell types (central nervous system, hematopoietic cells) where FAK expression might be lower

      • Compare responses to specific stimuli known to preferentially activate one kinase over the other

  • Subcellular localization studies:

    • Perform immunofluorescence with PTK2B (Ab-579) Antibody and FAK-specific antibodies

    • Compare localization patterns, as PTK2B and FAK may show different distributions in certain cell types

    • PTK2B can be found in the cytoplasm, perinuclear region, cell membrane, focal adhesions, and nucleus

How does PTK2B phosphorylation at Tyr579 contribute to cytoskeletal reorganization and cell adhesion?

PTK2B phosphorylation at Tyr579 plays crucial roles in cytoskeletal reorganization and cell adhesion through multiple mechanisms:

  • Activation of Rho family GTPases:

    • Phosphorylated PTK2B promotes activation of Rho family GTPases, such as RHOA and RAC1

    • These GTPases are master regulators of actin cytoskeleton dynamics

    • RHOA promotes stress fiber formation and focal adhesion maturation

    • RAC1 drives lamellipodia formation and membrane protrusion

  • Focal adhesion dynamics:

    • PTK2B localizes to focal adhesions when activated

    • Phosphorylation at Tyr579 enhances PTK2B kinase activity, enabling it to phosphorylate focal adhesion proteins like paxillin (PXN)

    • This phosphorylation regulates adhesion assembly, maturation, and turnover

    • The dynamic regulation of focal adhesions is essential for controlled cell migration

  • Integrin signaling integration:

    • PTK2B functions downstream of integrin receptors

    • Phosphorylation at Tyr579 contributes to integrin-mediated signaling

    • This signaling regulates cell adhesion to extracellular matrix components

    • PTK2B colocalizes with integrins at the cell periphery

  • Scaffold function for signaling complexes:

    • Phosphorylated PTK2B serves as a platform for recruiting signaling proteins involved in cytoskeletal regulation

    • It interacts with SRC family kinases, which phosphorylate additional cytoskeletal regulators

    • These interactions facilitate signal transduction from adhesion receptors to the cytoskeleton

  • Cell type-specific functions:

    • In immune cells, PTK2B phosphorylation regulates cytoskeletal changes needed for migration to inflammatory sites

    • In neurons, it contributes to growth cone dynamics and synaptic plasticity

    • In osteoclasts, it promotes cytoskeletal arrangements required for bone resorption

Why might I observe variability in PTK2B (Ab-579) Antibody detection across different cell types?

Variability in PTK2B (Ab-579) Antibody detection across different cell types can result from several factors:

  • Expression level differences:

    • PTK2B expression varies naturally between cell types

    • Some immune cells, neurons, and osteoclasts express relatively high levels

    • Epithelial cells may express lower levels

    • Quantify total PTK2B expression using qRT-PCR or Western blotting with antibodies against total protein

  • Basal phosphorylation state:

    • Different cell types maintain varying levels of basal PTK2B phosphorylation

    • This depends on intrinsic signaling activity and culture conditions

    • Serum starvation prior to experiments may help standardize basal phosphorylation

  • Epitope accessibility issues:

    • Protein-protein interactions may mask the epitope around Tyr579

    • PTK2B interacts with numerous proteins depending on cell type and activation state

    • Different cell types may have different PTK2B binding partners affecting epitope accessibility

  • Protein extraction efficiency:

    • Cell type-specific differences in membrane composition and cytoskeletal structure

    • May require optimization of lysis conditions for each cell type

    • Consider using different detergents or extraction methods for challenging cell types

  • Post-translational modifications:

    • Other post-translational modifications near Tyr579 might affect antibody binding

    • These modifications could vary between cell types

    • Phosphorylation at nearby residues (e.g., Tyr580) might influence epitope recognition

  • Technical considerations:

    • Optimize fixation and permeabilization for each cell type in immunofluorescence

    • Adjust antibody concentration based on expression levels (1:500-1:3000 for Western blot, 1:50-1:200 for immunofluorescence)

    • Consider different blocking reagents to reduce non-specific binding

What stimuli or treatments effectively induce PTK2B phosphorylation at Tyr579?

Several stimuli and treatments can effectively induce PTK2B phosphorylation at Tyr579:

  • Calcium-elevating agents:

    • Calcium ionophores (A23187, ionomycin)

    • Thapsigargin (sarco/endoplasmic reticulum Ca2+-ATPase inhibitor)

    • Store-operated calcium entry activators

  • G-protein coupled receptor (GPCR) activators:

    • Angiotensin II

    • L-alpha-lysophosphatidic acid (LPA)

    • Chemokines relevant to the cell type being studied

  • Integrin activators:

    • Plating cells on fibronectin, collagen, or other ECM proteins

    • Integrin-activating antibodies

    • Manganese chloride (activates integrins)

  • Growth factors and cytokines:

    • Epidermal growth factor (EGF)

    • Platelet-derived growth factor (PDGF)

    • Cell type-specific cytokines

  • Mechanical stimuli:

    • Fluid shear stress

    • Substrate stiffness modulation

    • Cell stretching

  • Oxidative stress inducers:

    • Hydrogen peroxide (H₂O₂)

    • Other reactive oxygen species (ROS) generators

    • PTK2B activation can be mediated by ROS production

  • Physiological triggers:

    • In immune cells: antigen receptor engagement, chemokine stimulation

    • In neurons: neurotransmitter stimulation, particularly activating NMDA receptors

    • In osteoclasts: RANKL stimulation

  • Therapeutic relevance:

    • Small molecule inhibitors targeting upstream kinases can be used to determine the pathway leading to Tyr579 phosphorylation

    • SRC family kinase inhibitors would be expected to reduce Tyr579 phosphorylation after stimulation

How should sample preparation be optimized to preserve PTK2B phosphorylation status?

Preserving PTK2B phosphorylation status during sample preparation requires careful attention to several factors:

  • Rapid sample processing:

    • Minimize time between cell harvesting and protein extraction

    • Keep samples on ice throughout processing

    • Work efficiently to reduce phosphatase activity time

  • Effective phosphatase inhibition:

    • Include multiple phosphatase inhibitors in all buffers:

      • Sodium orthovanadate (1-2 mM) for tyrosine phosphatases

      • Sodium fluoride (5-10 mM) for serine/threonine phosphatases

      • β-glycerophosphate (10 mM) for serine/threonine phosphatases

      • Phosphatase inhibitor cocktails containing multiple inhibitors

    • Pre-activate sodium orthovanadate by boiling and adjusting pH to maximize inhibitory activity

  • Lysis buffer composition:

    • Use non-denaturing lysis buffer with moderate detergent concentration:

      • RIPA buffer (1% NP-40 or Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS)

      • Add protease inhibitors (PMSF, aprotinin, leupeptin, pepstatin)

      • Include EDTA (1-2 mM) to chelate calcium and inhibit calcium-dependent proteases

  • Temperature control:

    • Maintain samples at 4°C during lysis and processing

    • Avoid freeze-thaw cycles of lysates

    • If freezing is necessary, snap-freeze in liquid nitrogen and store at -80°C

  • Loading buffer considerations:

    • Add reducing agent (DTT or β-mercaptoethanol) to SDS sample buffer immediately before use

    • Limit heating time during sample denaturation (5 minutes at 95°C is typically sufficient)

    • Consider using lower temperatures (70°C) for longer times if phosphorylation is labile

  • Tissue-specific considerations:

    • For tissues: snap-freeze immediately after collection

    • Use a tissue homogenizer with the appropriate buffer

    • Consider using phosphatase inhibitor perfusion for animal tissues when possible

  • Verification approach:

    • Run parallel samples with and without phosphatase inhibitors to demonstrate their effectiveness

    • Include positive controls (e.g., cells treated with pervanadate) to verify phosphoprotein detection

What factors might affect the stability and performance of PTK2B (Ab-579) Antibody?

Several factors can influence the stability and performance of PTK2B (Ab-579) Antibody:

  • Storage conditions:

    • Store as recommended, typically at -20°C or -80°C

    • Avoid repeated freeze-thaw cycles by preparing small aliquots

    • For working solutions, store at 4°C for short-term use

    • Most products are supplied in buffers containing 50% glycerol to prevent freezing damage

  • Buffer composition:

    • The antibody is typically provided in PBS with 50% glycerol, 0.5% BSA, and 0.02% sodium azide

    • This formulation helps maintain antibody stability

    • Avoid introducing contaminants that may promote microbial growth or protein degradation

  • Physical handling:

    • Minimize exposure to direct light, particularly for fluorophore-conjugated versions

    • Avoid vortexing antibody solutions vigorously (can cause protein denaturation)

    • Centrifuge briefly before opening tubes to collect solution at the bottom

  • Chemical stability factors:

    • pH extremes can denature antibodies; maintain neutral pH

    • Reducing agents can break disulfide bonds; avoid unless specifically required

    • Some detergents at high concentrations can denature antibodies

  • Contamination issues:

    • Use sterile technique when handling antibody solutions

    • Avoid introducing bacteria or fungi that could degrade the antibody

    • Sodium azide (0.02%) in the storage buffer helps prevent microbial growth

  • Application-specific considerations:

    • For immunohistochemistry: fixation type and antigen retrieval method can impact epitope accessibility

    • For Western blotting: transfer efficiency and blocking conditions affect performance

    • For immunoprecipitation: binding capacity of beads and wash stringency influence results

  • Lot-to-lot variation:

    • Polyclonal antibodies like PTK2B (Ab-579) Antibody may show some variation between production lots

    • Test new lots alongside previous lots when possible

    • Consider validation experiments when switching to a new lot

How can I optimize antibody dilution and incubation conditions for different applications?

Optimizing antibody dilution and incubation conditions for different applications requires systematic testing:

Western Blotting Optimization:

  • Antibody dilution:

    • Start with the manufacturer's recommended range (1:500-1:3000)

    • Prepare a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:3000)

    • Select the dilution that gives the best signal-to-noise ratio

    • Higher concentrations increase sensitivity but may also increase background

  • Incubation conditions:

    • Time: Test overnight (16h) at 4°C versus 1-3 hours at room temperature

    • Temperature: 4°C incubations generally give cleaner results but require longer times

    • Agitation: Gentle rocking or shaking improves antibody access to the membrane

  • Blocking optimization:

    • Test different blocking agents (5% non-fat dry milk, 5% BSA, commercial blockers)

    • For phospho-specific detection, BSA is generally preferred over milk

    • Optimize blocking time (30 minutes to 2 hours)

Immunohistochemistry/Immunofluorescence Optimization:

  • Antibody dilution:

    • Use the recommended range (1:50-1:300 for IHC, 1:50-1:200 for IF)

    • Prepare a dilution series to determine optimal concentration

    • Higher concentrations may be needed for weakly expressed proteins

  • Incubation conditions:

    • Time: Test 1 hour at room temperature versus overnight at 4°C

    • Humidity: Use a humidified chamber to prevent sample drying

    • For tissue sections, extend incubation times compared to cell monolayers

  • Antigen retrieval:

    • Test different methods (heat-induced epitope retrieval, enzymatic retrieval)

    • Optimize pH and buffer composition for heat-induced retrieval

    • Adjust retrieval time based on signal strength and tissue integrity

ELISA Optimization:

  • Antibody dilution:

    • Start with high dilution (1:10000-1:20000)

    • Prepare a broad dilution series to establish a standard curve

    • Optimize for the linear range of detection

  • Incubation conditions:

    • Temperature: Room temperature or 37°C

    • Time: 1-2 hours typical for primary antibody

    • Shaking: Gentle orbital shaking improves binding kinetics

Optimization Table for Different Applications:

ApplicationStarting DilutionDilution RangeIncubation TimeTemperatureBlocking Recommendation
Western Blot1:10001:500-1:3000Overnight4°C5% BSA in TBST
IHC1:1001:50-1:3001-2 hoursRT1-5% normal serum
IF1:1001:50-1:2001-2 hoursRT1-5% BSA in PBS
ELISA1:100001:5000-1:200001-2 hoursRT1-3% BSA in PBS

Optimization Strategy:

  • Start with the middle of the recommended dilution range

  • Test one variable at a time while keeping others constant

  • Document all conditions and results systematically

  • Include appropriate controls with each experiment

  • Once optimized, maintain consistent conditions for experimental reproducibility

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.